The diagnostic performance of [18F]FET PET/MRI versus [18F]FDG PET/MRI for recurrent glioma: a systematic review and meta-analysis

被引：2
作者：
Huo, Huasong [1 ]
Shen, Shurui [2 ]
Zhang, Lanyue [1 ]
Yang, Fuwei [3 ]
Li, Yunqian [1 ]
机构：
[1] First Hosp Jilin Univ, Dept Neurosurg, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Dept Plast & Cosmet Surg, Changchun, Peoples R China
[3] Jilin Univ, Dept Neurosurg, China Japan Union Hosp, Changchun, Peoples R China
来源：
CLINICAL AND TRANSLATIONAL IMAGING | 2023年 / 11卷 / 03期
关键词：
F-18]FET PET; MRI; F-18]FDG PET; Diagnostic performance; Glioma; Recurrent; Meta-analysis; MAGNETIC-RESONANCE-SPECTROSCOPY; POSITRON-EMISSION-TOMOGRAPHY; F-18-FDG PET; MRI; RADIONECROSIS; FDG; DIFFERENTIATION; NEUROONCOLOGY; BEVACIZUMAB; ACCURACY;
D O I：
10.1007/s40336-023-00563-7
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PurposeOur systematic review and meta-analysis aimed to evaluate the diagnostic performance of [F-18]FDG PET/MRI vs. [F-18]FET PET/MRI for recurrent glioma.MethodsWe searched for relevant articles in PubMed, Embase, and Web of Science until February 2023. Studies regarding the diagnostic performance of [F-18]FET PET/MRI or [F-18]FDG PET/MRI in recurrent glioma were included. The quality of each study was assessed using the Quality Assessment of Diagnostic Performance Studies-2 (QUADAS-2) tool.ResultsA total of nine studies with 310 patients were included in the analysis, the pooled sensitivity, specificity of [F-18]FDG PET/MRI in detecting recurrent glioma after definitive treatment were 0.99 (95% CI 0.75-1.00) and 0.62 (95% CI 0.37-0.83), [F-18]FET PET/MRI were 0.94 (95% CI 0.81-0.98) and 0.87 (95% CI 0.70-0.95), respectively. The area under curve (AUC) for [F-18]FDG PET/MRI and [F-18]FET PET/MRI were 0.92 (95% CI 0.89-0.94) and 0.96 (95% CI 0.94-0.97) and there is a statistical difference between the two imaging modalities (Z = 12.433, P < 0.001). Fagan nomogram indicated that when the pre-test probability was set at 50%, the post-test probability for [F-18]FDG PET/MRI and [F-18]FET PET/MRI could increase to 72 and 88%.Conclusions[F-18]FET PET/MRI has a higher AUC compared to [F-18]FDG PET/MRI in the detection of tumor recurrence in glioma. However, the results of the meta-analysis were drawn from studies with small samples. Further larger prospective studies in this setting are warranted.
引用
收藏
页码：285 / 295
页数：11
相关论文
共 47 条
[1]   Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas [J].
Albert, Nathalie L. ;
Weller, Michael ;
Suchorska, Bogdana ;
Galldiks, Norbert ;
Soffietti, Riccardo ;
Kim, Michelle M. ;
La Fougere, Christian ;
Pope, Whitney ;
Law, Ian ;
Arbizu, Javier ;
Chamberlain, Marc C. ;
Vogelbaum, Michael ;
Ellingson, Ben M. ;
Tonn, Joerg C. .
NEURO-ONCOLOGY, 2016, 18 (09) :1199-1208
[2]   Combined PET/MRI in brain glioma imaging [J].
Almansory, Karar O. ;
Fraioli, Francesco .
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2019, 80 (07) :380-386
[3]   Pseudoprogression and pseudoresponse in the treatment of gliomas [J].
Brandsma, Dieta ;
van den Bent, Martin J. .
CURRENT OPINION IN NEUROLOGY, 2009, 22 (06) :633-638
[4]   PET radiotracers in glioma: a review of clinical indications and evidence [J].
Castello, Angelo ;
Castellani, Massimo ;
Florimonte, Luigia ;
Ciccariello, Gabriele ;
Mansi, Luigi ;
Lopci, Egesta .
CLINICAL AND TRANSLATIONAL IMAGING, 2022, 10 (05) :535-551
[5]   Multimodal imaging based on MRI and PET reveals [18F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma [J].
Corroyer-Dulmont, Aurelien ;
Peres, Elodie A. ;
Gerault, Aurelie N. ;
Savina, Ariel ;
Bouquet, Fanny ;
Divoux, Didier ;
Toutain, Jerome ;
Ibazizene, Meziane ;
MacKenzie, Eric T. ;
Barre, Louisa ;
Bernaudin, Myriam ;
Petit, Edwige ;
Valable, Samuel .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (04) :682-694
[6]   Diagnostic Accuracy of PET for Differentiating True Glioma Progression From Post Treatment-Related Changes: A Systematic Review and Meta-Analysis [J].
Cui, Meng ;
Zorrilla-Veloz, Rocio Isabel ;
Hu, Jian ;
Guan, Bing ;
Ma, Xiaodong .
FRONTIERS IN NEUROLOGY, 2021, 12
[7]   Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas [J].
Daniels, D. ;
Guez, D. ;
Last, D. ;
Hoffmann, C. ;
Nass, D. ;
Talianski, A. ;
Tsarfaty, G. ;
Salomon, S. ;
Kanner, A. A. ;
Blumenthal, D. T. ;
Bokstein, F. ;
Harnof, S. ;
Yekutieli, D. ;
Zamir, S. ;
Cohen, Z. R. ;
Zach, L. ;
Mardor, Y. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (11) :2003-2009
[8]   PET/MRI in prostate cancer: a systematic review and meta-analysis [J].
Evangelista, Laura ;
Zattoni, Fabio ;
Cassarino, Gianluca ;
Artioli, Paolo ;
Cecchin, Diego ;
dal Moro, Fabrizio ;
Zucchetta, Pietro .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (03) :859-873
[9]  
Fountas K., 2019, EPILEPSY SURG INTRIN, DOI [10.1007/978-3-319-95918-4, DOI 10.1007/978-3-319-95918-4]
[10]   Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review [J].
Furuse, Motomasa ;
Nonoguchi, Naosuke ;
Yamada, Kei ;
Shiga, Tohru ;
Combes, Jean-Damien ;
Ikeda, Naokado ;
Kawabata, Shinji ;
Kuroiwa, Toshihiko ;
Miyatake, Shin-Ichi .
RADIATION ONCOLOGY, 2019, 14 (1)
12345